|
|
 |
|
Viewing report
|
|
 |
ARIAD Pharmaceuticals Inc.
Sheila Greco Associates, May 2011, Pages: 2
ARIAD is engaged in the discovery and development of breakthrough medicines that regulate cell signaling with small molecules. The Company is developing a comprehensive approach to the treatment of cancer and is primarily focused on a series of product candidates for targeted oncology indications. ARIAD also has an exclusive license to pioneering technology and patents related to the discovery, development and use of drugs that regulate NF-(kappa)B cell-signaling activity, which has been implicated in many major diseases.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
 |
|
|